Earnings Feed
Start Free
Home/Filings/4/0000899243-17-000987
4//SEC Filing

Mirati Therapeutics, Inc. 4

Accession 0000899243-17-000987

CIK 0001576263operating
View on SEC.govCompany Profile

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 5:00 PM ET

Size

30.1 KB

Accession

0000899243-17-000987

Insider Transaction Report

Form 4
Period: 2017-01-06
Mirati Therapeutics, Inc.MRTX
LEWIS JOSEPH
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
Holdings

  • Common Stock

    13,131

  • Common Stock

    37,241

  • Common Stock

    87,052

  • Common Stock

    77,038

  • Common Stock

    30,518
Boxer Asset Management Inc.
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
Holdings

  • Common Stock

    13,131

  • Common Stock

    87,052

  • Common Stock

    37,241

  • Common Stock

    30,518

  • Common Stock

    77,038
Boxer Capital, LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
Holdings

  • Common Stock

    87,052

  • Common Stock

    77,038

  • Common Stock

    13,131

  • Common Stock

    37,241

  • Common Stock

    30,518
LIEBERBURG IVAN M
10% Owner
Transactions
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
Holdings

  • Common Stock

    37,241

  • Common Stock

    13,131

  • Common Stock

    77,038

  • Common Stock

    30,518

  • Common Stock

    87,052
Dissanayake Shehan Bharatha
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
Holdings

  • Common Stock

    30,518

  • Common Stock

    37,241

  • Common Stock

    13,131

  • Common Stock

    77,038

  • Common Stock

    87,052
MVA Investors, LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
Holdings

  • Common Stock

    13,131

  • Common Stock

    30,518

  • Common Stock

    37,241

  • Common Stock

    77,038

  • Common Stock

    87,052
LAPPE RODNEY W
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
Holdings

  • Common Stock

    37,241

  • Common Stock

    87,052

  • Common Stock

    30,518

  • Common Stock

    13,131

  • Common Stock

    77,038
Davis Aaron I.
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
Holdings

  • Common Stock

    87,052

  • Common Stock

    13,131

  • Common Stock

    77,038

  • Common Stock

    30,518

  • Common Stock

    37,241
Reisman Neil
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
Holdings

  • Common Stock

    30,518

  • Common Stock

    37,241

  • Common Stock

    13,131

  • Common Stock

    77,038

  • Common Stock

    87,052
Fuglesang Christopher
10% Owner
Transactions
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+6,104$34,182→ 435,444 total
  • Purchase

    Common Stock

    2017-01-06$5.60/sh+280,059$1,568,330→ 1,037,994 total
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+51,047$285,812→ 51,047 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (51,047 underlying)
  • Purchase

    Warrant (right to purchase)

    2017-01-06$5.60/sh+2,341,786$13,111,660→ 2,341,786 total
    Exercise: $0.00From: 2017-01-06→ Common Stock (2,341,786 underlying)
Holdings

  • Common Stock

    37,241

  • Common Stock

    87,052

  • Common Stock

    30,518

  • Common Stock

    13,131

  • Common Stock

    77,038
Footnotes (9)
  • [F1]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, (iii) Boxer Asset Management Inc. ("Boxer Management"), (v) MVA Investors, LLC ("MVA Investors"), (vi) Joe Lewis, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the "Boxer Group), and indirectly by Boxer Management and Messrs.
  • [F2](Continued from Footnote 1) Lewis, Fuglesang, Reisman, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  • [F3]These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  • [F4]These securities are owned directly by Christopher Fuglesang, who may be deemed to be a member of the Boxer Group, and includes 11,436 shares received in connection with the pro rata distribution by Boxer Capital to its members on March 16, 2016 (the "Boxer Capital Pro Rata Distribution").
  • [F5]These securities are owned directly by Neil Reisman, who may be deemed to be a member of the Boxer Group, and includes 4,921 shares received in connection with the Boxer Capital Pro Rata Distribution.
  • [F6]These securities are owned directly by Ivan M. Lieberburg, who may be deemed to be a member of the Boxer Group, and includes 34,981 shares received in connection with the Boxer Capital Pro Rata Distribution.
  • [F7]These securities are owned directly by Shehan B. Dissanayake, who may be deemed to be a member of the Boxer Group, and includes 28,869 shares received in connection with the Boxer Capital Pro Rata Distribution.
  • [F8]These securities are owned directly by Aaron I. Davis, who may be deemed to be a member of the Boxer Group, and includes 32,622 shares received in connection with the Boxer Capital Pro Rata Distribution.
  • [F9]The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.

Documents

1 file

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001576263

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:00 PM ET
Size
30.1 KB
View on SEC.gov